Cargando…

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma

Purpose: To develop and validate a decision aid to help make individualized estimates of tumor recurrence for patients with resected combined hepatocellular cholangiocarcinoma (CHC). Patients and methods: Risk factors of recurrence were identified in the derivation cohort of 208 patients who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Meng-Xin, Luo, Liu-Ping, Liu, Wei-Ren, Deng, Wei, Yin, Jia-Cheng, Jin, Lei, Jiang, Xi-Fei, Zhou, Yu-Fu, Qu, Wei-Feng, Tang, Zheng, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qiu, Shuang-Jian, Zhou, Jian, Liu, Jing-Feng, Fan, Jia, Shi, Ying-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556465/ https://www.ncbi.nlm.nih.gov/pubmed/31239773 http://dx.doi.org/10.2147/CMAR.S195964

Ejemplares similares

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis
por: Zhou, Pei-Yun, et al.
Publicado: (2017)

Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma
por: Tang, Zheng, et al.
Publicado: (2019)

Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis
por: Tao, Chen-Yang, et al.
Publicado: (2018)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020)

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2018)

Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection
por: Zhang, Mei‐xia, et al.
Publicado: (2018)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study
por: Gan, Wei, et al.
Publicado: (2018)

Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2016)

Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection
por: Jiang, Xing-Xing, et al.
Publicado: (2020)

Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
por: Sun, Hui-Chuan, et al.
Publicado: (2017)

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
por: Sun, Bao-Ye, et al.
Publicado: (2023)

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
por: Qu, Wei-Feng, et al.
Publicado: (2023)

A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article
por: Fu, Yi-Peng, et al.
Publicado: (2016)

The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis
por: Tang, Youyin, et al.
Publicado: (2021)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection
por: Chen, Fei-Yu, et al.
Publicado: (2020)

Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study
por: Gan, Wei, et al.
Publicado: (2018)

Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness
por: Tang, Wei, et al.
Publicado: (2021)

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection
por: Xiao, Han, et al.
Publicado: (2021)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Evaluation of the short-term outcomes of robotic-assisted radical resection for perihilar cholangiocarcinoma: a propensity-scored matching analysis
por: Huang, Xi-Tai, et al.
Publicado: (2023)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma
por: Chen, Peizhan, et al.
Publicado: (2016)

Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching
por: Zhang, Wenli, et al.
Publicado: (2020)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study
por: Wu, Yijun, et al.
Publicado: (2022)

Development and validation of a mutation-annotated prognostic score for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study
por: Wang, Xiang-Yu, et al.
Publicado: (2023)

Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS(ICC)‐applied prediction model
por: Tian, Mengxin, et al.
Publicado: (2020)

Evaluating prognostic value of biliary stone in intrahepatic cholangiocarcinoma by propensity score matching analysis
por: Wang, Yupeng, et al.
Publicado: (2023)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection
por: Qu, Zhen, et al.
Publicado: (2022)

Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
por: Zhang, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mk60o3fvgt84ai6tncgp66jjp